| 7358374 |
Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
Robert W. McLaughlin, Constantine Sklavounos |
2008-04-15 |
| 6906202 |
Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
Robert W. McLaughlin, Constantine Sklavounos |
2005-06-14 |
| 6436961 |
Pharmaceutical agents for the treatment of emesis |
William M. Snyder, Glenn E. Wilcox |
2002-08-20 |
| 5939550 |
Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
Tamim F. Braish, Michael Castaldi |
1999-08-17 |
| 5804562 |
Spirostanyl glycosidal crystals |
Douglas J. M. Allen, Richard Allen Buzon, Michael P. DeNinno, Jonathan B. Zung |
1998-09-08 |
| 5760009 |
Spirostanyl glycosidal crystalline monohydrate |
Douglas J. M. Allen, Jonathan B. Zung |
1998-06-02 |
| 4736059 |
Process for the preparation of meso 2,5-dihaloadipates |
Brian Thomas O'Neill |
1988-04-05 |
| 4467090 |
Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3, 4,5-tetrahydro-1H-pyrido[4,3-b]indole |
Stephen S. Massett |
1984-08-21 |
